Investors need to watch only one number to figure out what returns are going to look like, Gross says.
Goldman shares are up 34 percent versus the S&P 500's 6 percent return since the Nov. 8 election.
Some of the names on the move ahead of the open.
The bond market is wrestling with the Trump trade.
More than $18 billion in U.S. deals were announced Monday, bringing 2017's deal values to more than twice the same period last year.
Theresa May reminded markets Brexit could be a hard hit, and it's in the EU's interest to make sure that's the case, analysts said.
These are the stocks posting the largest moves after the bell on Monday: Barracuda Networks, Williams Companies, World Wrestling Entertainment and more.
Stocks and commodities could see a final 10 percent melt-up in the first half of the year, followed by a "meltdown," closer to 2018.
Shares of Acuity Brands dropped nearly 15 percent after the lighting solutions provider reported weaker-than-expected quarterly results.
The gains in Fiat Chrysler, Alibaba and LVMH contrast with the declines in other stocks after negative comments from Donald Trump.
Trump's policies have the potential to trigger a new age in U.S. growth that could serve as a global template, according to Deutsche Bank.
Ariad Pharmaceuticals investors are having a good day.
Lee believes the first half will see the market slide from its current record perch, then rally just enough to get back to unchanged.
Check out Monday's early movers: URBN, SCAI, UNH, MCD & more
Anbang is in talks to invest in a project to redevelop a building owned by Kushner Cos., run by U.S. President-elect Donald Trump's son-in-law Jared Kushner.
The Dow Jones industrial average came within 0.37 points of reaching 20,000 on Friday, but that doesn't tell the whole story.
Fewer than 1 in 5 large-cap active managers — 19 percent — produced returns that beat the Russell 1000 market index, according to BofAML.
A push by Washington for more business-friendly regulation and fiscal support could improve America's policy mix, a Fed governor said.
Traders are looking for more details on the Trump agenda in the week ahead, and that could help steer the "Trump trade."
CEO Stack said 2016 was a year of solid execution for the company that set the stage for continued growth of its pain-relief drug, Exparel.
Get the best of CNBC in your inbox